Research location
Goyang-si
Gyeonggi-do, South Korea
Advertisement
Research activity in Goyang-si
Gyeonggi-do, South KoreaCureCurrent currently publishes aggregate city-level research activity for this location: 184 trials and 188 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Goyang-si
184 linked trials · page 2 of 4Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast CancerNCT04478266 · 2020-10-14 · 1 site observation
TERMINATED
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)NCT04410991 · 2020-06-11 · 1 site observation
COMPLETED
Brigatinib in ALK-positive NSCLC Identified Via Blood-based AssaysNCT04074993 · 2020-05-15 · 1 site observation
UNKNOWN
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung CancerNCT04155034 · 2020-05-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic SurgeryNCT04585074 · 2020-04-08 · 1 site observation
ACTIVE_NOT_RECRUITING
Anti-HER2 Bispecific Antibody Zanidatamab (ZW25) Activity in Combination With Chemotherapy With/Without TislelizumabNCT04276493 · 2020-03-23 · 1 site observation
COMPLETED
Vortioxetine in Patients With Depression and Early DementiaNCT04294654 · 2020-02-28 · 1 site observation
COMPLETED
A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung CancerNCT04194944 · 2020-02-17 · 1 site observation
ACTIVE_NOT_RECRUITING
Clinical Trial of YH25448(Lazertinib) as the First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic NSCLC (LASER301)NCT04248829 · 2020-02-13 · 1 site observation
COMPLETED
Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid TumorsNCT04215978 · 2020-01-30 · 1 site observation
COMPLETED
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast CancerNCT03975647 · 2019-10-02 · 1 site observation
ACTIVE_NOT_RECRUITING
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET DysregulationNCT04052971 · 2019-08-01 · 1 site observation
COMPLETED
Prospective Cohort Study of Breast Cancer Patients Treated With RadiotherapyNCT04203849 · 2019-07-03 · 1 site observation
ENROLLING_BY_INVITATION
Life Style Modification for Breast Canccer Survivors Using Mobile App-based Human Coaching ProgramNCT05506189 · 2019-05-14 · 1 site observation
COMPLETED
Study of Lorlatinib in ROS1 Rearranged NSCLCNCT03612154 · 2019-05-02 · 1 site observation
UNKNOWN
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung CancerNCT03596866 · 2019-04-19 · 1 site observation
COMPLETED
A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential HypertensionNCT03897868 · 2019-03-21 · 1 site observation
COMPLETED
A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or CeritinibNCT03535740 · 2019-01-31 · 1 site observation
COMPLETED
Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%NCT03808480 · 2019-01-23 · 1 site observation
UNKNOWN
Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]NCT03734029 · 2018-12-27 · 1 site observation
COMPLETED
A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South KoreaNCT04470817 · 2018-08-07 · 1 site observation
COMPLETED
The Effect of Home Blood Pressure Measurement on the Management of HypertensionNCT03868384 · 2018-08-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Lenvatinib in Combination With Pembrolizumab Versus Treatment of Physician's Choice in Participants With Advanced Endometrial Cancer (MK-3475-775/E7080-G000-309 Per Merck Standard Convention [KEYNOTE-775])NCT03517449 · 2018-06-11 · 1 site observation
COMPLETED
Curative Proton Beam Therapy for Patients With Lung Metastasis of Colorectal CancerNCT03566355 · 2018-05-23 · 1 site observation
UNKNOWN
A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)NCT03472560 · 2018-05-02 · 1 site observation
TERMINATED
Sequential Hypofractionated Radiotherapy Followed by Anti-PD-L1 Atezolizumab for SCLCNCT03262454 · 2018-01-22 · 1 site observation
UNKNOWN
Therapeutic Effect of Sodium Intake Reduction in Treatment Resistant HypertensionNCT03424317 · 2018-01-01 · 1 site observation
TERMINATED
Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line TherapyNCT03315364 · 2017-12-18 · 1 site observation
ACTIVE_NOT_RECRUITING
Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPCNCT03395197 · 2017-12-18 · 2 site observations
ACTIVE_NOT_RECRUITING
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking TamoxifenNCT02819921 · 2017-11-10 · 1 site observation
TERMINATED
PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid TumorsNCT03284723 · 2017-11-01 · 1 site observation
TERMINATED
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast CancerNCT03233191 · 2017-09-28 · 1 site observation
ACTIVE_NOT_RECRUITING
First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590)NCT03189719 · 2017-07-25 · 1 site observation
COMPLETED
A Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple SclerosisNCT05366036 · 2017-06-14 · 2 site observations
COMPLETED
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)NCT03142334 · 2017-06-09 · 1 site observation
COMPLETED
Korean Lung Cancer Screening ProjectNCT03394703 · 2017-04-10 · 1 site observation
UNKNOWN
International Breast Cancer Biomarker,Standard of Care and Real World Outcomes StudyNCT03078036 · 2017-03-13 · 1 site observation
COMPLETED
Efficacy and Safety Study of Pembrolizumab (MK-3475) Versus Paclitaxel in Asian Participants With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Who Progressed After First-line Therapy With Platinum and Fluoropyrimidine (MK-3475-063/KEYNOTE-063)NCT03019588 · 2017-02-16 · 1 site observation
TERMINATED
Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLCNCT03046992 · 2017-02-15 · 1 site observation
COMPLETED
Study of DHP1401 in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil(DRAMA)NCT03055741 · 2016-12-28 · 1 site observation
COMPLETED
Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer PatientsNCT03222258 · 2016-12-17 · 1 site observation
COMPLETED
A Study of Tarceva vs. Avastin+Tarceva for Advanced NSCLC With EGFR m(+)NCT03126799 · 2016-11-01 · 1 site observation
UNKNOWN
Study of Metformin and S. Baicalensis Combination Therapy in Type 2 Diabetes Mellitus PatientsNCT02844803 · 2016-07-01 · 1 site observation
UNKNOWN
Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung CancerNCT02991924 · 2016-07-01 · 1 site observation
UNKNOWN
A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease DementiaNCT02783573 · 2016-07-01 · 1 site observation
TERMINATED
Effect of Evogliptin on Bone Metabolism in HumanNCT02587975 · 2016-06-01 · 1 site observation
UNKNOWN
ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) ParticipantsNCT02737501 · 2016-05-26 · 1 site observation
COMPLETED
Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQNCT02548949 · 2016-04-25 · 1 site observation
COMPLETED
A Prospective Clinical Study for Evaluation of Safe Resection Margin in Breast Conserving Surgery in Breast CancerNCT02817334 · 2016-03-01 · 1 site observation
UNKNOWN
A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsNCT02573259 · 2016-02-10 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.